.png)
Focus: Rare Diseases including Neuromyelitis Optics Spectrum Disorder, Urea Cycle Disorders, Nephropathic Cystinosis and Cystic Fibrosis
Horizon, now part of Amgen, is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare diseases.
